SavedAdd your journal

Journals / MN Oftalmoloji / 2009 / Cilt: 16 - Sayı: 2

The Effect of Systemic Risk Factors on Branch and Central Retinal Vein Occlusions

Retinal Ven Dal ve Kök Tıkanıklıklarında Sistemik Risk Faktörlerinin Etkisi

Nihal DEMİR
Mehmet Numan ALP
Soner KESKİN
Gülcan KURAL
Pages
108–111
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Although the patients with BRVO and the patients with CRVO are similar for the presence of diabetes mellitus, systemic hypertension, and hyperlipidemia, hyperhomocysteinemia seems to be a more important risk factor for patients with CRVO.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To compare the patients with branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) for the presence of systemic risk factors, such as diabetes mellitus, systemic hypertension, hyperlipidemia, and hyperhomocysteinemia.
📊
Key Findings & Data:Material and Method: We evaluated the presence of systemic hypertension, diabetes mellitus, hyperlipidemia, and hyperhomocysteinemia prospectively in a total of 38 patients, 28 with BRVO and 10 with CRVO, who have been followed up in our clinic.
💡
Conclusion & Impact:Conclusions: Although the patients with BRVO and the patients with CRVO are similar for the presence of diabetes mellitus, systemic hypertension, and hyperlipidemia, hyperhomocysteinemia seems to be a more important risk factor for patients with CRVO.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To compare the patients with branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) for the presence of systemic risk factors, such as diabetes mellitus, systemic hypertension, hyperlipidemia, and hyperhomocysteinemia. Material and Method: We evaluated the presence of systemic hypertension, diabetes mellitus, hyperlipidemia, and hyperhomocysteinemia prospectively in a total of 38 patients, 28 with BRVO and 10 with CRVO, who have been followed up in our clinic. Results: Seven patients (25%) with BRVO had concurrent diabetes mellitus. None of the patients with CRVO had diabetes mellitus. Fifteen patients (54%) with BRVO and 6 patients (60%) with CRVO had systemic hypertension. Hyperlipidemia was detected in 4 patients (14%) with BRVO, whereas none of the patients with CRVO had hyperlipidemia. The difference between the patients with BRVO and CRVO for the presence of diabetes mellitus, hypertension, and hyperlipidemia was not statistically significant (p>0.05). However, 5 patients (18%) with BRVO and 6 patients (60%) with CRVO had hyperhomocysteinemia and the difference between the two groups was statistically significant (p=0.019). Conclusions: Although the patients with BRVO and the patients with CRVO are similar for the presence of diabetes mellitus, systemic hypertension, and hyperlipidemia, hyperhomocysteinemia seems to be a more important risk factor for patients with CRVO.

Özet

Amaç: Retinal ven dal tıkanıklığı (RVDT) ve santral retinal ven tıkanıklığı (SRVT) olgularının diabetes mellitus, sistemik hipertansiyon, hiperlipidemi ve hiperhomosisteinemi gibisistemik risk faktörlerinin varlığı yönünden karşılaştırılması.Gereç ve Yöntem: Kliniğimizin Retina biriminde, 2005-2008 yılları arasında, 28'i RVDT,10'u ise SRVT tanısı ile takip edilen toplam 38 hasta sistemik hipertansiyon, diabetes mellitus, hiperlipidemi, hiperhomosisteinemi varlığı yönünden prospektif olarak incelendi.Bulgular: Retinal ven dal tıkanıklığı grubundaki 7 hastada (%25) aynı zamanda diabetesmellitus mevcuttu. Santral retinal ven tıkanıklığı grubundaki hiçbir hastada diabetes mellitussaptanmadı. Hipertansiyon RVDT grubunda 15 hastada (%54), SRVT grubunda ise 6 hastada (%60) mevcuttu. Retinal ven dal tıkanıklığı grubunda 4 hastada (%14) hiperlipidemi saptanırken, SRVT grubundaki hiçbir olguda hiperlipidemi mevcut değildi. Diabetes mellitus, sistemik hipertansiyon ve hiperlipidemi varlığı yönünden RVDT ve SRVT grupları arasında istatistiksel olarak anlamlı fark saptanmadı (p>0,05). Bununla birlikte, RVDT grubunda 5 hastada (%18) homosistein düzeyi normal sınırların üzerindeyken, SRVT grubunda 6 hastada(%60) hiperhomosisteinemi tespit edildi. İki grup arasındaki fark istatistiksel olarak anlamlıydı (p=0,019).Sonuç: Retinal ven dal tıkanıklığı ve SRVT olguları diabetes mellitus, sistemik hipertansiyon ve hiperlipidemi varlığı yönünden benzer özellikler göstermekle birlikte, hiperhomosisteinemi SRVT olgularında daha önemli bir risk faktörü gibi görünmektedir

🔖

Cite This Article

DEMİR, N., ALP, M. N., KESKİN, S., KURAL, G. (2009). The Effect of Systemic Risk Factors on Branch and Central Retinal Vein Occlusions. MN Oftalmoloji, Cilt: 16 - Sayı: 2, 108–111. https://ajindex.com/articles/295855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Cooney MJ, Fekrat S, Finkelstein D. Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol 1998; 9:47-50. Nwosu SN. Prevalence and pattern of retinal diseases at the Guinness Eye Hospital, Onitsha, Nigeria. Ophthalmic Epidemiol 2000; 7: 41-8.
  2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1243-7.
  3. Wong TY, Larsen EKM, Klein R, Mitchell P, Couper DJ. Cardiovascular risk factors for retinal vein occlusion and arte- riolar emboli. The atherosclerosis risk in communities- Cardiovascular health studies. Ophthalmology 2005; 112: 540-7.
  4. O'Mahoney PRA, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008; 126:692-9.
  5. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten- year inci- dence of retinal vein occlusion in an older population. Arch Ophthalmol 2006; 124:726-732.
  6. Hayreh SS, Zimmerman B, McCarthy MJ, Belhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001; 131:61-77. Eye Disease Case-Control Study Group.Risk factors for cen- tral retinal vein occlusion. Arch Ophthalmol 1996; 114:545-54. Eye Disease Case-Control Study Group.Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993; 116: 286-96. Williamson T. Central retinal vein occlusion: what's the story? Br J Ophthalmol 1997; 81:698-704. Janssen MCH, den Heijer M, Cruysberg JRM, Wollersheim H, Bredie SJH. Retinal vein occlusion: a form of venous throm- bosis or a complication of atherosclerosis? Thromb Haemost 2005; 93:1021-6.
  7. Salaun N, Delyfer MN, Rougier MB, Korobelnik JF. Assess - ment of risk factors for retinal vein occlusions in patients under 60 years of age. J Fr Ophthalmol 2007; 30:918-23.
  8. Yıldırım C, Yaylalı V, Tatlıpınar S, Kaptanoğlu B, Akpınar S. Hyperhomocysteinemia: a risk factor for retinal vein occlu- sion. Opthalmologica 2004; 218:102-6. Vine AK. Hyperhomocysteinemia: a risk factor for central reti- nal vein occlusion. Am J Ophthalmol 2000; 129:640-4. Vine AK. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 2000; 98:493-503.
  9. Brown BA, MarxJL, Ward TP, Holliferd RD, Dick JS. Homocysteine: a risk factor for retinal venous occlusive dis- ease. Ophthalmology 2002; 109:287-90.
  10. Cahill M, Karabatzaki M, Meleady R, Refsum H, Shields D. Raised plasma homocysteine as a risk factor for retinal